Oxidative Medicine and Cellular Longevity | Vol.2019, Issue. | | Pages
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease
Reactive oxygen species (ROS) and autophagy are two highly complex and interrelated components of cell physiopathology, but our understanding of their integration and their contribution to cell homeostasis and disease is still limited. Sestrins (SESNs) belong to a family of highly conserved stress-inducible proteins that orchestrate antioxidant and autophagy-regulating functions protecting cells from various noxious stimuli, including DNA damage, oxidative stress, hypoxia, and metabolic stress. They are also relevant modulators of metabolism as positive regulators of the key energy sensor AMP-dependent protein kinase (AMPK) and inhibitors of mammalian target of rapamycin complex 1 (mTORC1). Since perturbations in these pathways are central to multiple disorders, SESNs might constitute potential novel therapeutic targets of broad interest. In this review, we discuss the current understanding of regulatory and effector networks of SESNs, highlighting their significance as potential biomarkers and therapeutic targets for different diseases, such as aging-related diseases, metabolic disorders, neurodegenerative diseases, and cancer.
Original Text (This is the original text for your reference.)
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease
Reactive oxygen species (ROS) and autophagy are two highly complex and interrelated components of cell physiopathology, but our understanding of their integration and their contribution to cell homeostasis and disease is still limited. Sestrins (SESNs) belong to a family of highly conserved stress-inducible proteins that orchestrate antioxidant and autophagy-regulating functions protecting cells from various noxious stimuli, including DNA damage, oxidative stress, hypoxia, and metabolic stress. They are also relevant modulators of metabolism as positive regulators of the key energy sensor AMP-dependent protein kinase (AMPK) and inhibitors of mammalian target of rapamycin complex 1 (mTORC1). Since perturbations in these pathways are central to multiple disorders, SESNs might constitute potential novel therapeutic targets of broad interest. In this review, we discuss the current understanding of regulatory and effector networks of SESNs, highlighting their significance as potential biomarkers and therapeutic targets for different diseases, such as aging-related diseases, metabolic disorders, neurodegenerative diseases, and cancer.
+More
effector networks stressinducible proteins protein kinase autophagy regulatory disease dna damage oxidative stress hypoxia antioxidant energy sensor noxious stimuli metabolism sesns cancer oxygen species ros cell physiopathology autophagyregulating agingrelated diseases metabolic disorders neurodegenerative
APA
MLA
Chicago
,.Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease. 2019 (),.
Select your report category*
Reason*
New sign-in location:
Last sign-in location:
Last sign-in date: